COMBIVIR (H.J. Harkins Company, Inc.)
Welcome to the PulseAid listing for the COMBIVIR drug offered from H.J. Harkins Company, Inc.. This Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | H.J. Harkins Company, Inc. |
NON-PROPRIETARY NAME: | lamivudine and zidovudine |
SUBSTANCE NAME: | LAMIVUDINE; ZIDOVUDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-10-19 |
END MARKETING DATE: | 0000-00-00 |
COMBIVIR HUMAN PRESCRIPTION DRUG Details:
Item Description | COMBIVIR from H.J. Harkins Company, Inc. |
LABELER NAME: | H.J. Harkins Company, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150; 300(mg/1; mg/1) |
START MARKETING DATE: | 2010-10-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52959-546_37641156-8d51-4e36-abb6-b46cb9e7f828 |
PRODUCT NDC: | 52959-546 |
APPLICATION NUMBER: | NDA020857 |
Other LAMIVUDINE; ZIDOVUDINE Pharmaceutical Manufacturers / Labelers: